Millennium Management’s Soleno Therapeutics SLNO Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $53.1M | Sell |
633,721
-45,570
| -7% | -$3.82M | 0.03% | 537 |
|
2025
Q1 | $48.5M | Buy |
679,291
+202,490
| +42% | +$14.5M | 0.03% | 529 |
|
2024
Q4 | $21.4M | Buy |
476,801
+221,912
| +87% | +$9.97M | 0.01% | 1065 |
|
2024
Q3 | $12.9M | Sell |
254,889
-203,631
| -44% | -$10.3M | 0.01% | 1387 |
|
2024
Q2 | $18.7M | Buy |
458,520
+366,295
| +397% | +$14.9M | 0.01% | 1113 |
|
2024
Q1 | $3.95M | Buy |
92,225
+78,542
| +574% | +$3.36M | ﹤0.01% | 2150 |
|
2023
Q4 | $551K | Sell |
13,683
-41,773
| -75% | -$1.68M | ﹤0.01% | 3127 |
|
2023
Q3 | $1.64M | Buy |
+55,456
| New | +$1.64M | ﹤0.01% | 2613 |
|
2023
Q1 | – | Sell |
-45,876
| Closed | -$91K | – | 4936 |
|
2022
Q4 | $91K | Buy |
+45,876
| New | +$91K | ﹤0.01% | 4327 |
|
2022
Q3 | – | Sell |
-3,088
| Closed | -$9K | – | 5494 |
|
2022
Q2 | $9K | Buy |
+3,088
| New | +$9K | ﹤0.01% | 5008 |
|
2021
Q3 | – | Sell |
-12,998
| Closed | -$222K | – | 5440 |
|
2021
Q2 | $222K | Buy |
+12,998
| New | +$222K | ﹤0.01% | 4658 |
|
2020
Q4 | – | Sell |
-4,074
| Closed | -$153 | – | 4357 |
|
2020
Q3 | $153 | Buy |
4,074
+1,340
| +49% | +$50 | ﹤0.01% | 3324 |
|
2020
Q2 | $91K | Sell |
2,734
-6,280
| -70% | -$209K | ﹤0.01% | 3259 |
|
2020
Q1 | $322K | Buy |
+9,014
| New | +$322K | ﹤0.01% | 2521 |
|